The treatment of patients with lung cancer happens according to ESMO multidisciplinary guidelines, in cooperation between respiratory oncology, thoracic surgery, thoracic radiotherapy, pathology and the molecular lab.
There are two tumor boards per week, one on multidisciplinary treatment for earlier stage patients and one on molecular tumor board on systemic therapy for advanced stage patients.